Zapanta JB, Gorospe C. Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer after Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report. apjcc [Internet]. 14Jul.2025 [cited 16Jul.2025];10(3):989-92. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/1534